We are the world’s largest publicly-funded international collaboration focused on the development of vaccines to prevent HIV/AIDS. Learn more >
Our sites conduct all phases of clinical trials - from evaluating experimental vaccines for safety and immunogenicity to testing vaccine efficacy. Learn more >
Worldwide, thousands of people have participated in HIV vaccine trials. Volunteers are the heroes of vaccine development. Learn more >
Independent Data Safety and Monitoring Board makes recommendation to stop all injections in Phase 2/3b study named HVTN 702, Uhambo due to lack of vaccine efficacy.
Community Compass aims to keep the HVTN community informed about the Network’s research, sites' activities, and advances in the field of HIV Prevention and Vaccination. Read the current issue >
The HIV Vaccine Trials Network, in collaboration with the National Institute of Mental Health and the National Institute of Allergy and Infectious Diseases, is investing in the next generation of HIV prevention researchers by providing African American and Latinx medical students with opportunities for independent research along with structured mentoring, project and salary funding, training, and professional development activities. Learn more >
We support the next generation of HIV researchers with structured mentoring, projects, training, and networking opportunities. Learn more >
Getting the right test will prevent an incorrect diagnosis of HIV. Your study site or VISP Testing Service can provide the right test. Visit our frequently asked questions for more information.